Trust Company of Toledo’s Takeda Pharmaceutical TAK Stock Holding History

Trust Company of Toledo’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.03K	Hold	376	–	–	﹤0.01%	747
2026 Q1	$6.96K	Hold	376	–	–	﹤0.01%	669
2025 Q4	$5.86K	Hold	376	–	–	﹤0.01%	651
2025 Q3	$5.5K	Hold	376	–	–	﹤0.01%	660
2025 Q2	$5.81K	Buy	+376	New	+$5.56K	﹤0.01%	651
2019 Q3	–	Sell	-11,179	Closed	-$197K	–	180
2019 Q2	$197K	Sell	11,179 -186	-2%	-$3.38K	0.05%	170
2019 Q1	$231K	Buy	+11,365	New	+$229K	0.06%	163

Other funds holding TAK

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

CCA

Catalyst Capital Advisors Huntington, New York $6.03B AUM 24.5% 1-Year Est. Return

CCA

Carrera Capital Advisors Troy, Michigan $675M AUM 17.92% 1-Year Est. Return

LWAM

Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return

SGI

Summit Global Investments Bountiful, Utah $1.83B AUM 22.56% 1-Year Est. Return

Trust Company of Toledo's TAK Position: Q2 2026 in Review

Trust Company of Toledo held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 376 shares worth $6.03K. The position accounts for ﹤0.01% of the portfolio, ranked #747.

Trust Company of Toledo first reported a position in TAK in Q1 2019 and has held it in 7 quarters since. The position peaked at $231K in Q1 2019. 147 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Trust Company of Toledo held 376 shares of Takeda Pharmaceutical worth $6.03K as of Q2 2026.
Trust Company of Toledo left its Takeda Pharmaceutical share count unchanged in Q2 2026.
Takeda Pharmaceutical made up ﹤0.01% of Trust Company of Toledo's portfolio in Q2 2026, its #747 holding.
Trust Company of Toledo first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 7 quarters since.
Trust Company of Toledo's Takeda Pharmaceutical position peaked at $231K in Q1 2019.
147 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Trust Company of Toledo's 13F filing for Q2 2026, filed 16 Jul 2026.